Cite
MLA Citation
Stefan Sturm et al.. “A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier.” British journal of clinical pharmacology, vol. 85, no. 1, 2019, pp. 181–193. http://access.bl.uk/ark:/81055/vdc_100076294880.0x000042